Every story in this section, newest first — page 242 of 373.
Kopin (NASDAQ:KOPN), a developer of application-specific optical systems and high-performance microdisplays, today announced preliminary unaudited financial results for the fourth quarter ended December 27, 2025.
Yunji (NASDAQ:YJ), a leading membership-based social e-commerce platform in China, today announced its unaudited financial results for the second half and fiscal year ended December 31, 2025.
Huize Holding (NASDAQ:HUIZ), a leading digital insurance product and service platform in China, today announced record-breaking financial and operational results for the full year ended December 31, 2025.
Boqii Holding (NYSE:BQ), a long-term destination for pet lovers in China, today reported its unaudited financial results for the six months ended September 30, 2025.
Pharming Group (NASDAQ:PHAR), a global biopharmaceutical company dedicated to transforming the lives of patients with rare diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion.
Netflix (NASDAQ:NFLX) shares climbed 1.1% to $93.32 on Thursday, providing a much-needed lift for the stock following a period of underperformance.
Shares of Meta Platforms (NASDAQ:META) fell more than 8% on Thursday following a landmark Los Angeles jury verdict that found the company, alongside Google parent Alphabet (NASDAQ:GOOGL) negligent in protecting young users from addictive platform designs.
Lucid Diagnostics (NASDAQ:LUCD), a commercial-stage medical diagnostics company focused on the early detection of esophageal precancer, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025.
GigaMedia (NASDAQ:GIGM), a major provider of online games and cloud computing services, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.
Sypris Solutions (NASDAQ:SYPR), a diversified provider of outsourced services and specialty products, today reported financial results for its fourth quarter and full year ended December 31, 2025.
BRP (NASDAQ:DOOO), the global leader in powersports vehicles and propulsion systems, today announced its financial results for the fourth quarter and full fiscal year ended January 31, 2026.
Innate Pharma (NASDAQ:IPHA), a clinical-stage biotechnology company developing next-generation immunotherapies for cancer, today reported its consolidated financial results for the full year ended December 31, 2025.
Meta Platforms (NASDAQ:META) is executing a strategic reorganization of its nearly 79,000-person workforce, laying off 700 employees across Reality Labs, social media, sales, and talent acquisition.
Hyperion DeFi (NASDAQ:HYPD), the inaugural U.S. publicly traded entity dedicated to the Hyperliquid ecosystem, today reported financial results for the fourth quarter and full year ended December 31, 2025.
Novocure (NASDAQ:NVCR), a global oncology company at the forefront of cancer treatment innovation, today announced positive topline results from its Phase 2 PANOVA-4 clinical trial.
BioLineRx (NASDAQ:BLRX), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced the initiation of a first-in-human Phase 1/2a clinical trial evaluating GLIX1 for the treatment of recurrent and progressive glioblastoma (GBM) and other high-grade gliomas.
MeiraGTx Holdings (NASDAQ:MGTX), a vertically integrated, clinical-stage genetic medicines company, today reported financial results for the full year ended December 31, 2025, and provided a comprehensive update on its late-stage clinical pipeline.
Foresight Autonomous Holdings (NASDAQ:FRSX), an innovator in automotive vision systems, today reported financial results for the fourth quarter and full year ended December 31, 2025.
Interlink Electronics (NASDAQ:LINK), a global leader in human-machine interface and sensor technologies, today reported financial results for the fourth quarter ended December 31, 2025.
Formula Systems (NASDAQ:FORTY), a global information technology holding company, today reported record-breaking financial results for the fourth quarter and full year ended December 31, 2025.
CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetic medicine company developing innovative technologies based on its proprietary plant-derived recombinant human collagen (rhCollagen), today reported financial results for the full year ended December 31, 2025.
MetaVia (NASDAQ:MTVA), a clinical-stage biopharmaceutical company developing novel therapies for obesity and metabolic-associated steatohepatitis (MASH), today reported financial results for the full year ended December 31, 2025, and provided an update on its advancing clinical pipeline.
ParaZero Technologies (NASDAQ:PRZO), an aerospace company focused on drone safety systems for commercial and defense applications, today reported its financial results for the full year ended December 31, 2025.
OceanPal (NASDAQ:SVRN), a company historically focused on the dry bulk shipping sector, today reported its financial results for the full year ended December 31, 2025
